Guided Therapeutics provides update on U.S. trial for LuViva cervical scan

Guided Therapeutics (GTHP) announced it had enrolled enough patients, approximately 430, to begin closing out its U.S. FDA clinical trial for the LuViva Advanced Cervical Scan. The company is now moving to the data analysis phase, which includes external review of biopsy samples and statistical analysis. The company expects to file the clinical report with the FDA later this year and noted there have been no adverse events linked to the LuViva device.